<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03559231</url>
  </required_header>
  <id_info>
    <org_study_id>DUO-RESECT</org_study_id>
    <nct_id>NCT03559231</nct_id>
  </id_info>
  <brief_title>Endoscopic Resection of Non-ampullary Duodenal Adenomas: Endoscopic Mucosal Resection (EMR) vs. Endoscopic Full-thickness Resection With the 'Duodenal Full-thickness Resection Device' (dFTRD)</brief_title>
  <acronym>DUO-RESECT</acronym>
  <official_title>Endoscopic Resection of Non-ampullary Duodenal Adenomas: Endoscopic Mucosal Resection (EMR) vs. Endoscopic Full-thickness Resection With the 'Duodenal Full-thickness Resection Device' (dFTRD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kliniken Ludwigsburg-Bietigheim gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kliniken Ludwigsburg-Bietigheim gGmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized multi-center trial. Comparison of Endoscopic Mucosal Resection (EMR)
      versus Endoscopic Full-Thickness Resection with the duodenal Full-Thickness Resection Device
      (dFTRD) of non-ampullary duodenal adenomas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized multi-center trial. Comparison of Endoscopic Mucosal Resection (EMR)
      versus Endoscopic Full-Thickness Resection with the duodenal Full-Thickness Resection Device
      (dFTRD) of non-ampullary duodenal adenomas.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2018</start_date>
  <completion_date type="Anticipated">May 12, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 12, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complication Rate</measure>
    <time_frame>30 days</time_frame>
    <description>Composite endpoint of perforations and relevant bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>intraoperative</time_frame>
    <description>Rate of macroscopic complete resections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>'R0'-Resection</measure>
    <time_frame>within one week after resection (as soon as result of pathologic analysis of resected specimen is available)</time_frame>
    <description>Rate of microscopic complete resections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of 'en bloc' resections</measure>
    <time_frame>within one week after resection (as soon as result of pathologic analysis of resected specimen is available)</time_frame>
    <description>Rate of 'en bloc' resections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of secondary surgical intervention</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure time</measure>
    <time_frame>30 days</time_frame>
    <description>time span of the procedure according to sedation protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of patients with residual or recurrent duodenal adenoma at the follow-up endoscopy after 3 months</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of patients with residual or recurrent duodenal adenoma at the follow-up endoscopy after 1 year</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of necessary re-endoscopies</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Duodenal Adenoma</condition>
  <arm_group>
    <arm_group_label>dFTRD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic full-thickness resection of the duodenal adenoma with the 'duodenal Full-Thickness resection device' (dFTRD).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopic Mucosal Resection (EMR) of the duodenal adenoma (=standard therapy).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>dFTRD</intervention_name>
    <description>Duodenal Full-Thickness Resection</description>
    <arm_group_label>dFTRD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EMR</intervention_name>
    <description>Endoscopic Mucosal Resection</description>
    <arm_group_label>EMR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  duodenal adenoma

          -  age 18 or older

          -  written informed consent

        Exclusion Criteria:

          -  duodenal adenomas with a size &gt; 25 mm

          -  duodenal adenomas with 20 mm or less distance to the major and/or minor duodenal
             papilla

          -  presence of two or more duodenal adenomas

          -  suspected or histologically confirmed malignancy

          -  tumor disease (exception: after successful curative treatment)

          -  conditions/diseases of the upper GI-tract that impair advancing of the devices into
             the duodenum

          -  moribund patient

          -  pregnancy and breastfeeding

          -  patients that cannot give informed consent (e.g. psychiatric disorders, language
             barrier,...)

          -  other contraindications for duodenal resections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karel Caca, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Klinikum Ludwigsburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Markus Bauder, MD</last_name>
    <phone>+49(0)7141-99-67201</phone>
    <email>markus.bauder@kliniken-lb.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karel Caca, MD, PhD</last_name>
    <phone>+49(0)7141-99-67201</phone>
    <email>karel.caca@kliniken-lb.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <state>Baden-WÃ¼rttemberg</state>
        <zip>71640</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karel Caca, Prof. Dr. med.</last_name>
      <phone>+49(0)7141-99-67201</phone>
      <email>karel.caca@kliniken-lb.de</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Wennemuth</last_name>
      <phone>+49(0)7141-99-94473</phone>
      <email>sandra.wennemuth@kliniken-lb.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>June 5, 2018</last_update_submitted>
  <last_update_submitted_qc>June 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>duodenal adenoma</keyword>
  <keyword>FTRD</keyword>
  <keyword>dFTRD</keyword>
  <keyword>EMR</keyword>
  <keyword>endoscopic mucosal resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

